14
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Lack of Effect of Nizatidine on Drug Metabolism

Pages 18-23 | Published online: 08 Jul 2009
 

Abstract

H2-receptor antagonists are among the most widely-used drugs in the world and, since many patients receive a variety of other drugs concomitantly, it is important to investigate the interaction potential of new H2-receptor antagonists such as nizatidine. It is well documented that cimetidine can inhibit the hepatic elimination of many drugs by binding to the cytochrome P-450 system. Therefore we investigated in vitro and in vivo the effects of nizatidine on drug metabolism. With rat liver microsomes the effects of nizatidine and four other H2-blockers (cimetidine, oxmetidine, ranitidine, famotidine) on the activity of three marker enzymes (aryl-hydrocarbon-hydroxylase, 7-ethoxycoumarin-O-deethylase, 7-ethoxy-resorufin-O-deethylase) were tested. While cimetidine and oxmetidine exhibited marked and dose-dependent inhibition of all three metabolic reactions, nizatidine showed some weak inhibition only at very high concentrations. Similarly, binding to cytochrome P-450 of human liver microsomes could be seen only with cimetidine and oxmetidine, whereas nizatidine did not affect the binding spectra. In nine healthy male volunteers the pharmacokinetics of diazepam (10 mg po) was studied under the influence of nizatidine (300 mg day nocte). Nizatidine had no significant effect on the hepatic elimination of diazepam, as characterized by its elimination half-life (mean ± SD) of 35.3 ± 24.2 h (control) and 37.3 ± 18.3 h (+ nizatidine) or its total plasma clearance of 28.2 ± 12.0 ml/min (control) and 26.7 ± 10.4 ml/min (+ nizatidine). The formation of the major metabolite—desmethyldiazepam—was also unaffected by nizatidine. Likewise, the hepatic elimination of chlordiazepoxide, lorazepam, theophylline/aminophylline, warfarin, lidocaine, metoprolol and antipyrine were not impaired by nizatidine. Therefore it could be concluded that nizatidine seems to be devoid of an interaction potential on the level of hepatic drug metabolism.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.